We are live on ! Find out more

DMTX

Dimension Therapeutics, Inc

DMTX

Delisted

DMTX was delisted on the 6th of November, 2017.

55 hedge funds and large institutions have $90M invested in Dimension Therapeutics, Inc in 2016 Q4 according to their latest regulatory filings, with 10 funds opening new positions, 18 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New

Increased

Maintained

Reduced

Closed

50% more repeat investments, than reductions

Existing positions increased: 18 | Existing positions reduced: 12

11% more first-time investments, than exits

New positions opened: 10 | Existing positions closed: 9

2% more funds holding

Funds holding: 54 → 55 (+1)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

47% less capital invested

Capital invested by funds: $170M → $90M (-$80M)

Holders

Holders Change

Holders Change %

+1.85%

% of All Funds

1.38%

Holding in Top 10

Holding in Top 10 Change

–

Holding in Top 10 Change %

–

% of All Funds

0.03%

New

Increased

Reduced

Closed

Calls

–

Puts

–

Net Calls

–

Net Calls Change

–

Top Buyers

1	Millennium Management New York	+$932K
2	WMSA Weiss Multi-Strategy Advisers New York	+$670K
3	BFA BlackRock Fund Advisors San Francisco, California	+$297K
4	Renaissance Technologies New York	+$288K
5	State Street Boston, Massachusetts	+$269K

Top Sellers

1	PHS PFM Health Sciences San Francisco, California	-$3.56M
2	RCM RA Capital Management Boston, Massachusetts	-$3.3M
3	Asset Management One Tokyo, Japan	-$906K
4	JHIU Janus Henderson Investors US Denver, Colorado	-$320K
5	SIM Spark Investment Management New York	-$302K

#	Name	Holding	Trade Value	Shares Change	Change in Stake
26	TI 26 Turner Investments Berwyn, Pennsylvania	$131K	+$160K	+30,100	New
27	27 Russell Investments Group London, United Kingdom	$114K	+$136K	+25,565	New
28	28 California State Teachers Retirement System (CalSTRS) West Sacramento, California	$109K	-$4.26K	-800	-3%
29	29 Squarepoint New York	$106K	+$130K	+24,370	New
30	30 Wells Fargo San Francisco, California	$93K	+$62.1K	+11,663	+121%
31	31 Susquehanna International Group Bala Cynwyd, Pennsylvania	$87K	+$107K	+20,078	New
32	32 Goldman Sachs New York	$86K	-$5.58K	-1,049	-5%
33	NFA 33 Nationwide Fund Advisors Columbus, Ohio	$85K	+$64K	+12,025	+161%
34	TA 34 Teachers Advisors New York	$84K	–	–	–
35	35 Deutsche Bank Frankfurt Am Main Ge, Germany	$72K	+$79K	+14,847	+687%
36	TC 36 TFS Capital West Chester, Pennsylvania	$61K	-$9.65K	-1,814	-11%
37	37 Charles Schwab San Francisco, California	$57K	–	–	–
38	38 Citigroup New York	$54K	+$60.2K	+11,313	+1,135%
39	39 RhumbLine Advisers Boston, Massachusetts	$44K	-$9.3K	-1,748	-15%
40	40 SG Americas Securities New York	$44K	+$54K	+10,145	New
41	AIG 41 American International Group New York	$31K	-$101	-19	-0.3%
42	42 New York State Common Retirement Fund Albany, New York	$29K	–	–	–
43	43 BlackRock New York	$23K	–	–	–
44	BA 44 BlackRock Advisors Wilmington, Delaware	$23K	+$3.58K	+672	+14%
45	45 UBS Group Zurich, Switzerland	$12K	-$1.49K	-280	-9%
46	MAM 46 Meeder Asset Management Dublin, Ohio	$9K	+$10.5K	+1,971	New
47	47 Bank of America Charlotte, North Carolina	$7K	+$6.24K	+1,172	+231%
48	48 Manulife (Manufacturers Life Insurance) Canada, Ontario, Canada	$3K	–	–	–
49	49 Royal Bank of Canada Toronto, Ontario, Canada	$3K	+$3.75K	+704	New
50	50 Legal & General Group London, United Kingdom	$3K	+$3.77K	+709	New

DMTX Hedge Fund Activity: Q4 2016 in Review

55 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in Dimension Therapeutics, Inc (DMTX) for Q4 2016, worth a combined $90M — down 47% from $170M a quarter earlier.

Buyers outnumbered sellers: 10 funds opened new DMTX positions and 9 closed out — a net gain of 1 holder — while 18 added to existing stakes and 12 trimmed.

The largest buyer was Millennium Management, opening a new position worth an estimated $932K. The largest seller was PFM Health Sciences, exiting entirely with an estimated $3.56M sold.

55 institutional investors held Dimension Therapeutics, Inc (DMTX) as of Q4 2016, up from 54 in Q3 2016.
Funds reported $90M of Dimension Therapeutics, Inc stock for Q4 2016, down 47% quarter-over-quarter.
10 funds opened new Dimension Therapeutics, Inc positions in Q4 2016 and 9 closed out, a net change of +1 holder.
The largest Dimension Therapeutics, Inc buyer in Q4 2016 was Millennium Management, an estimated $932K added.
The largest Dimension Therapeutics, Inc seller in Q4 2016 was PFM Health Sciences, an estimated $3.56M sold.

Based on aggregated 13F filings for Q4 2016.

Dimension Therapeutics, Inc DMTX